Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCMA Antikörper (AA 78-184)

TNFRSF17 Reaktivität: Human ELISA, IHC, Coat, IHC (f) Wirt: Maus Monoclonal BCMA-2366 unconjugated
Produktnummer ABIN6936646
  • Target Alle BCMA (TNFRSF17) Antikörper anzeigen
    BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
    Bindungsspezifität
    • 7
    • 7
    • 7
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 78-184
    Reaktivität
    • 55
    • 21
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 43
    • 14
    • 9
    Maus
    Klonalität
    • 42
    • 24
    Monoklonal
    Konjugat
    • 38
    • 9
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BCMA Antikörper ist unkonjugiert
    Applikation
    • 48
    • 38
    • 15
    • 13
    • 8
    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC), Coating (Coat), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    The B cell maturation protein (BCMA) is a type I integral membrane protein that belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is expressed as a 184 amino acid peptide that is expressed only in mature B-lymphocytes and is located on the cis part of the Golgi apparatus. BCMA shares significant homology with TACI (transmembrane activator) within the cysteine-rich domain. TACI has been shown to bind CAML, which induces activation of NFAT (nuclear factor of activated T cells). Both BCMA and TACI have been shown to bind APRIL and TALL-1, which stimulate B cell proliferation in conjunction with other B-cell activators. When overexpressed, TALL-1 stimulates the development of systemic lupus erythaematosus (SLE).
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant human CD269 protein fragment (around aa 78-184) (exact sequence is proprietary)
    Klon
    BCMA-2366
    Isotyp
    IgG2c kappa
    Top Product
    Discover our top product TNFRSF17 Primärantikörper
  • Applikationshinweise

    Known_Application: ELISA (For coating, order antibody without BSA),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: NAMALWA cells. Tonsil or gastric carcinoma (IHC).

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
    Andere Bezeichnung
    CD269 (TNFRSF17 Produkte)
    Synonyme
    TNFRSF17 antikoerper, BCM antikoerper, BCMA antikoerper, CD269 antikoerper, TNFRSF13A antikoerper, Tnfrsf13 antikoerper, Tnfrsf13a antikoerper, TNF receptor superfamily member 17 antikoerper, tumor necrosis factor receptor superfamily, member 17 antikoerper, Tnfrsf17 antikoerper, TNFRSF17 antikoerper
    Hintergrund
    B-cell maturation protein, BCMA, CD269, TNR17, Tumor necrosis factor receptor superfamily member 17 (TNFRSF17),CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein)
    Cellular localisation: Cell Surface
    Molekulargewicht
    20kDa
    Gen-ID
    608, 2556
    UniProt
    Q02223
Sie sind hier:
Kundenservice